A pyridoxal-phosphate protein that catalyzes the conversion of L-tyrosine to tyramine and carbon dioxide. The bacterial enzyme also acts on 3-hydroxytyrosine and, more slowly, on 3-hydroxyphenylalanine. (From Enzyme Nomenclature, 1992) EC 4.1.1.25.
An enzyme group with broad specificity. The enzymes decarboxylate a range of aromatic amino acids including dihydroxyphenylalanine (DOPA DECARBOXYLASE); TRYPTOPHAN; and HYDROXYTRYPTOPHAN.
Enzymes that catalyze the addition of a carboxyl group to a compound (carboxylases) or the removal of a carboxyl group from a compound (decarboxylases). EC 4.1.1.
One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of DOPA to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease.
A sodium-independent neutral amino acid transporter system with specificity for large amino acids. One of the functions of the transporter system is to supply large neutral amino acids to the brain.
A CD98 antigen light chain that when heterodimerized with CD98 antigen heavy chain (ANTIGENS, CD98 HEAVY CHAIN) forms a protein that mediates sodium-independent L-type amino acid transport.
A family of light chains that bind to the CD98 heavy chain (ANTIGENS, CD98 HEAVY CHAIN) to form a heterodimer. They convey functional specificity to the protein.
A class of amino acids characterized by a closed ring structure.
A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.
A heterodimeric protein that is a cell surface antigen associated with lymphocyte activation. The initial characterization of this protein revealed one identifiable heavy chain (ANTIGENS, CD98 HEAVY CHAIN) and an indeterminate smaller light chain. It is now known that a variety of light chain subunits (ANTIGENS, CD98 LIGHT CHAINS) can dimerize with the heavy chain. Depending upon its light chain composition a diverse array of functions can be found for this protein. Functions include: type L amino acid transport, type y+L amino acid transport and regulation of cellular fusion.
Cellular proteins and protein complexes that transport amino acids across biological membranes.
Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins.
A transmembrane glycoprotein subunit that can dimerize with a variety of light chain subunits (ANTIGENS, CD98 LIGHT CHAINS). This protein subunit serves a diverse array of functions including amino acid transport and cell fusion. Its function is altered depending which of the light chain subunits it interacts with.
'Amino Acid Transport System y+', also known as System Y+, is a sodium-independent cationic amino acid transporter that mediates the uptake of primarily basic amino acids, such as arginine and lysine, into cells through a facilitated diffusion process.
An essential branched-chain amino acid important for hemoglobin formation.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
An enzyme that catalyzes the decarboxylation of histidine to histamine and carbon dioxide. It requires pyridoxal phosphate in animal tissues, but not in microorganisms. EC 4.1.1.22.
Catalyzes the decarboxylation of an alpha keto acid to an aldehyde and carbon dioxide. Thiamine pyrophosphate is an essential cofactor. In lower organisms, which ferment glucose to ethanol and carbon dioxide, the enzyme irreversibly decarboxylates pyruvate to acetaldehyde. EC 4.1.1.1.
The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
The removal of a carboxyl group, usually in the form of carbon dioxide, from a chemical compound.
The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.
Amino acids containing an aromatic side chain.
A pyridoxal-phosphate protein, believed to be the rate-limiting compound in the biosynthesis of polyamines. It catalyzes the decarboxylation of ornithine to form putrescine, which is then linked to a propylamine moiety of decarboxylated S-adenosylmethionine to form spermidine.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
An enzyme that catalyzes the decarboxylation of S-adenosyl-L-methionine to yield 5'-deoxy-(5'-),3-aminopropyl-(1), methylsulfonium salt. It is one of the enzymes responsible for the synthesis of spermidine from putrescine. EC 4.1.1.50.
Organic compounds containing carbon and hydrogen in the form of an unsaturated, usually hexagonal ring structure. The compounds can be single ring, or double, triple, or multiple fused rings.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
Curved bacteria, usually crescent-shaped rods, with ends often tapered, occurring singly, in pairs, or short chains. They are non-encapsulated, non-sporing, motile, and ferment glucose. Selenomonas are found mainly in the human buccal cavity, the rumen of herbivores, and the cecum of pigs and several rodents. (From Bergey's Manual of Determinative Bacteriology, 9th ed)
This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
The naturally occurring or experimentally induced replacement of one or more AMINO ACIDS in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish, enhance, or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
An order of fungi in the phylum BASIDIOMYCOTA having macroscopic basidiocarps. The members are characterized by their saprophytic activities as decomposers, particularly in the degradation of CELLULOSE and LIGNIN. A large number of species in the order have been used medicinally. (From Alexopoulos, Introductory Mycology, 4th ed, pp504-68)
A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine.
The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the PYRUVATE DEHYDROGENASE COMPLEX and the KETOGLUTARATE DEHYDROGENASE COMPLEX.
An amino acid produced in the urea cycle by the splitting off of urea from arginine.
The rate dynamics in chemical or physical systems.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Polyamines are organic compounds with more than one amino group, involved in various biological processes such as cell growth, differentiation, and apoptosis, and found to be increased in certain diseases including cancer.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
A foul-smelling diamine formed by bacterial decarboxylation of lysine.
Proteins found in any species of bacterium.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Amino acids that are not synthesized by the human body in amounts sufficient to carry out physiological functions. They are obtained from dietary foodstuffs.
Organic compounds that are acyclic and contain three acid groups. A member of this class is citric acid which is the first product formed by reaction of pyruvate and oxaloacetate. (From Lehninger, Principles of Biochemistry, 1982, p443)
The relationships of groups of organisms as reflected by their genetic makeup.
Proteins prepared by recombinant DNA technology.
The functional hereditary units of BACTERIA.
The sum of the weight of all the atoms in a molecule.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
An intermediate compound in the metabolism of carbohydrates, proteins, and fats. In thiamine deficiency, its oxidation is retarded and it accumulates in the tissues, especially in nervous structures. (From Stedman, 26th ed)
Commonly observed structural components of proteins formed by simple combinations of adjacent secondary structures. A commonly observed structure may be composed of a CONSERVED SEQUENCE which can be represented by a CONSENSUS SEQUENCE.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion.
An essential amino acid that is required for the production of HISTAMINE.
A genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. Its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. Pathogenicity from this genus is rare.
The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH = log 1/2[1/(H+)], where (H+) is the hydrogen ion concentration in gram equivalents per liter of solution. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups.
Compounds consisting of two or more fused ring structures.
The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction.
A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.
Amino acids which have a branched carbon chain.
An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.
Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe.
A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.
The sequential correspondence of nucleotides in one nucleic acid molecule with those of another nucleic acid molecule. Sequence homology is an indication of the genetic relatedness of different organisms and gene function.

Aromatic L-amino acid decarboxylase: conformational change in the flexible region around Arg334 is required during the transaldimination process. (1/168)

Aromatic L-amino acid decarboxylase (AADC) catalytic mechanism has been proposed to proceed through two consecutive intermediates (i.e., Michaelis complex and the external aldimine). Limited proteolysis of AADC that preferentially digested at the C-terminal side of Arg334 was slightly retarded in the presence of dihydroxyphenyl acetate that formed a stable Michaelis complex. On the contrary, AADC was scarcely digested in the presence of L-dopa methyl ester that formed a stable external aldimine. Similar protection by the substrate analogs was observed in the chemical modification experiment. From these results, we concluded that the region around Arg334 must be exposed and flexible in the unliganded state, and forming the Michaelis complex generated a subtle conformational change, then underwent marked conformational change during the subsequent transaldimination process prerequisite to forming the external aldimine. For further analyses, we constructed a mutant gene encoding in tandem the two peptides of AADC cleaved at the Asn327-Met328 bond inside the putative flexible region. The gene product, fragmentary AADC, was still active with L-dopa as substrate, but its k(cat) value was decreased 57-fold, and the Km value was increased 9-fold compared with those of the wild-type AADC. The absorption spectra of the fragmentary AADC in the presence of L-dopa methyl ester showed shift in the equilibrium of the transaldimination from the external aldimine to the Michaelis complex. Tryptic digestion of the fragmentary AADC removed seven amino acid residues, Met328-Arg334, and resulted in complete inactivation. Susceptibility of the fragmentary enzyme to trypsin was not changed by L-dopa methyl ester revealing the loss of appropriate conformational change in the flexible region induced by substrate binding. From these results we propose that the conformational change in the flexible region is required during the transaldimination process.  (+info)

Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase enhance dopamine delivery after L-3, 4-dihydroxyphenylalanine administration in Parkinsonian rats. (2/168)

Medical therapy in Parkinson's disease (PD) is limited by the short-duration response and development of dyskinesia that result from chronic L-3,4-dihydroxyphenylalanine (L-DOPA) therapy. These problems occur partly because the loss of dopamine storage sites leads to erratic dopamine delivery. Vesicular monoamine transporter-2 (VMAT-2) plays a critical role in dopamine storage by packaging dopamine into synaptic vesicles and regulating sustained release of dopamine. To restore the capacity to produce and store dopamine in parkinsonian rats, primary skin fibroblast cells (PF) were genetically modified with aromatic L-amino acid decarboxylase (AADC) and VMAT-2 genes. After incubation with L-DOPA in culture, the doubly transduced fibroblast cells (PFVMAA) produced and stored dopamine at a much higher level than the cells with either gene alone. PFVMAA cells in culture released dopamine gradually in a constitutive manner. Genetically modified fibroblast cells were grafted in parkinsonian rat striata, and L-DOPA was systemically administered. Higher dopamine levels were sustained for a longer duration in rats grafted with PFVMAA cells than in those grafted with either control cells or cells with AADC alone. These findings underscore the importance of dopamine storage capacity in determining the efficacy of L-DOPA therapy and illustrate a novel method of gene therapy combined with precursor administration to overcome the major obstacles of PD treatment.  (+info)

Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. (3/168)

The present study examined renal dopaminergic activity and its response to high salt (HS) intake in adult (6-month-old) and old (24-month-old) Fischer 344 rats. Daily urinary excretion of L-3, 4-dihydroxyphenylalanine (L-DOPA), dopamine, and its metabolites 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid was similar in adult and old rats; by contrast, daily urinary excretion of norepinephrine in old rats was almost twice that in adult animals. HS intake (1% NaCl) over a period of 24 hours resulted in a 2-fold increase in the urinary excretion of dopamine, DOPAC, and norepinephrine in adult animals but not in old animals. Norepinephrine and L-DOPA plasma levels did not change during HS intake and were similar in both groups of rats. The natriuretic response to an HS intake in old rats (from 4.7+/-0.4 to 10.7+/-2.0 nmol. kg(-1). d(-1); Delta=6.0+/-0.9 nmol. kg(-1). d(-1)) was less than in adult rats (from 5.2+/-0.4 to 13.5+/-2.5 nmol. kg(-1). d(-1); Delta=8.3+/-0.8 nmol. kg(-1). d(-1)). A diuretic response to HS intake was observed in adult rats (from 20.9+/-2.3 to 37.6+/-2.8 mL. kg(-1). d(-1)) but not in old rats (from 37.7+/-5.7 to 42.3+/-6. 0 mL. kg(-1). d(-1)). Dopamine levels and dopamine/L-DOPA ratios in the renal cortex of old rats were greater than in adult rats. HS intake increased both dopamine levels and dopamine/L-DOPA ratios in the renal cortex of adult rats but not in old rats. Aromatic L-amino acid decarboxylase activity was higher in old rats than in adult rats; HS intake increased L-amino acid decarboxylase activity (nmol. mg protein(-1). l5 min(-1)) in adult rats (from 67+/-1 to 93+/-1) but not in old rats (from 86+/-2 to 87+/-2). Dopamine inhibited Na(+),K(+)-ATPase activity in proximal tubules obtained from adult rats, but it failed to exert such an inhibitory effect in old rats. It is concluded that renal dopaminergic tonus in old rats is higher than in adult rats but fails to respond to HS intake as observed in adult rats. This may be due in part to the inability of dopamine to inhibit Na(+),K(+)-ATPase activity in old rats.  (+info)

Expression of tryptophan decarboxylase and tyrosine decarboxylase genes in tobacco results in altered biochemical and physiological phenotypes. (4/168)

The substrate specificity of tryptophan (Trp) decarboxylase (TDC) for Trp and tyrosine (Tyr) decarboxylase (TYDC) for Tyr was used to modify the in vivo pools of these amino acids in transgenic tobacco. Expression of TDC and TYDC was shown to deplete the levels of Trp and Tyr, respectively, during seedling development. The creation of artificial metabolic sinks for Trp and Tyr also drastically affected the levels of phenylalanine, as well as those of the non-aromatic amino acids methionine, valine, and leucine. Transgenic seedlings also displayed a root-curling phenotype that directly correlated with the depletion of the Trp pool. Non-transformed control seedlings could be induced to display this phenotype after treatment with inhibitors of auxin translocation such as 2,3,5-triiodobenzoic acid or N-1-naphthylphthalamic acid. The depletion of aromatic amino acids was also correlated with increases in the activities of the shikimate and phenylpropanoid pathways in older, light-treated transgenic seedlings expressing TDC, TYDC, or both. These results provide in vivo confirmation that aromatic amino acids exert regulatory feedback control over carbon flux through the shikimate pathway, as well as affecting pathways outside of aromatic amino acid biosynthesis.  (+info)

Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies. (5/168)

A full-length rat cDNA clone encoding aromatic L-amino acid decarboxylase (AADC) (E.C. 4.1.1.28) was used for in vitro transcription and translation. The enzyme had catalytic activity (0. 2 pmol serotonin/microl lysate per min), and was stimulated 2.5-fold by the addition of excess pyridoxal phosphate. On size exclusion chromatography, AADC eluted as a single activity peak with an apparent mol. wt of 93 kD. This activity peak was immunoprecipitated by sera from patients with autoimmune polyendocrine syndrome type I (APS I) containing autoantibodies against AADC. Serum and purified IgG from these patients inhibited the enzyme activity (non-competitively) by 10-80%, while sera from APS I patients without autoantibodies and controls did not. This finding confirms and extends previous observations that APS I patients have inhibitory antibodies against key enzymes involved in neurotransmitter biosynthesis.  (+info)

Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats. (6/168)

We have previously shown that both renal dopamine (DA) and kallikrein-kinin systems are activated by exercise in mild hypertensives. We aimed to confirm the effects of exercise on the renal DA system and the stimulatory effects of DA on the renal kallikrein-kinin system in rats. In experiment 1, 12 male Dahl salt-sensitive (DS) rats given a 4% salt diet were divided into two groups. Rats in the exercise group were forced to run at 8 m/min, 60 min/day, 5 days/week for 4 weeks. Daily urinary volume, urinary excretion of sodium, free DA, and kallikrein activity were measured weekly. Renal aromatic-L-amino-acid decarboxylase (AADC) activities were assayed at the end of the experiment. In experiment 2, 15 male Sprague-Dawley (SD) rats were randomly divided into 3 groups, a DA-5 (5 microg of DA/kg/min), a DA-10 (10 microg of DA/kg/min), and a control group. DA or vehicle was administered subcutaneously with an osmotic pump for 2 weeks. Daily urinary volume, urinary excretion of sodium, aldosterone, DA, and kallikrein activity were measured weekly. Plasma renin activity, aldosterone concentration, and renal kallikrein mRNA levels were determined at the end of the experiment. In experiment 1, urinary excretion of free DA and renal AADC activities in the exercise group were significantly higher than those in the non-exercise group at week 4. In experiment 2, renal kallikrein mRNA levels and urinary volume were significantly increased in the DA-10 group compared to the control group, although there were no differences in urinary kallikrein activities. Plasma aldosterone concentration was significantly decreased in the DA-10 group compared to that in the control group despite a lack of differences in plasma renin activities. In conclusion, exercise increased the urinary excretion of free DA, probably through increased renal AADC activity in DS rats. DA amplified renal kallikrein mRNA levels and decreased plasma aldosterone levels, probably through its suppression of aldosterone in the adrenal glands. Activation of the kallikrein-kinin system might be counteracted by post-transcriptional modification of aldosterone. These results suggest that exercise enhances renal dopamine production by activating renal AADC activity, which in turn stimulates the renal kallikrein-kinin system.  (+info)

Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney. (7/168)

The present study evaluated renal and intestinal adaptations in sodium handling in uninephrectomized (Unx) rats and the role of dopamine. Two weeks after uninephrectomy, the remnant kidney in Unx rats weighed 33 +/- 2% more than the corresponding kidney in sham-operated (Sham) animals. This was accompanied by increases in urinary levels of dopamine and major metabolites [3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid] and increases in maximal velocity values (169 vs. 115 nmol. mg protein(-1). 15 min(-1)) for renal aromatic L-amino acid decarboxylase, the enzyme responsible for the synthesis of renal dopamine. High salt (HS) intake increased (P < 0.05) the urinary excretion of dopamine and DOPAC in Unx and Sham rats. However, the urinary levels of L-3,4-dihydroxyphenylalanine, dopamine, and DOPAC in Sham rats during HS intake were lower than in Unx rats. Blockade of dopamine D(1) receptors (Sch-23390, 2 x 30 microg/kg) reduced the urinary excretion of sodium in Unx (31% decrease) more pronouncedly than in Sham (19% decrease) rats. However, inhibition of renal Na(+)-K(+)-ATPase activity by dopamine was of similar magnitude in Unx and Sham rats. In parallel, it was observed that uninephrectomy resulted in a significant reduction in jejunal sodium absorption and Na(+)-K(+)-ATPase activity in jejunal epithelial cells. In jejunal epithelial cells from Sham rats, dopamine (1 microM) failed to inhibit Na(+)-K(+)-ATPase activity, whereas in Unx rats it produced a significant reduction. It is concluded that uninephrectomy results in increased renal dopaminergic activity and dopamine-sensitive enhanced natriuresis. Furthermore, it is suggested that decreased jejunal absorption of sodium may take place in response to partial renal ablation, as an example of renal-intestinal cross talk.  (+info)

The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. (8/168)

The carcinoid tumor is an uncommon neuroendocrine neoplasm the hallmark of which is excessive serotonin production. In studying kinetics of tryptophan hydroxylase and aromatic-L-amino acid decarboxylase (AAAD) in human carcinoid hepatic metastases and adjacent normal liver (J. A. Gilbert et al, Biochem. Pharmacol., 50: 845-850, 1995), we identified one significant difference: the Vmax of carcinoid AAAD was 50-fold higher than that in normal liver. Here, we report Western and Northern analyses detecting large quantities of AAAD polypeptide and mRNA in human carcinoid primary as well as metastatic tumors compared with normal surrounding tissues. To assess the feasibility of targeting these high AAAD levels for chemotherapy, AAAD inhibitors carbidopa (alpha-methyl-dopahydrazine), alpha-monofluoromethyldopa (MFMD), and 3-hydroxybenzylhydrazine (NSD-1015) were incubated (72 h) with NCI-H727 human lung carcinoid cells. Carbidopa and MFMD were lethal (IC50 = 29 +/- 2 microM and 56 +/- 6 microM, respectively); NSD-1015 had no effect on proliferation. On exposure to other human tumor lines, carbidopa was lethal only to NCI-H146 and NCI-H209 small cell lung carcinoma (SCLC) lines (IC50 = 12 +/- 1 microM and 22 +/- 5 microM, respectively). Carbidopa (100 microM) decreased growth of (but did not kill) SK-N-SH neuroblastoma and A204 rhabdomyosarcoma cells and did not affect proliferation of DU 145 prostate, MCF7 breast, or NCI-H460 large cell lung carcinoma lines. The rank order of lines by AAAD activity was NCI-H146 > NCI-H209 > SK-N-SH > NCI-H727, whereas A204, DU 145, MCF7, and NCI-H460 had no measurable activity. For lung tumor lines (carcinoid, two SCLC, and one large cell lung carcinoma), AAAD activity was correlated with the potency of carbidopa-induced cytotoxicity. However, carcinoid cell death was not solely attributable to complete inhibition of either AAAD activity or the serotonin synthetic pathway. In further evaluating potential applications of these findings with carbidopa, we determined that sublethal doses of carbidopa produced additive cytotoxic effects in carcinoid cells in combination with etoposide and cytotoxic synergy in SCLC cells when coincubated with topotecan.  (+info)

Tyrosine decarboxylase is an enzyme that catalyzes the decarboxylation of the amino acid tyrosine to form the biogenic amine tyramine. The reaction occurs in the absence of molecular oxygen and requires pyridoxal phosphate as a cofactor. Tyrosine decarboxylase is found in various bacteria, fungi, and plants, and it plays a role in the biosynthesis of alkaloids and other natural products. In humans, tyrosine decarboxylase is not normally present, but its activity has been detected in some tumors and is associated with the production of neurotransmitters in neuronal cells.

Aromatic-L-amino-acid decarboxylases (ALADs) are a group of enzymes that play a crucial role in the synthesis of neurotransmitters and biogenic amines in the body. These enzymes catalyze the decarboxylation of aromatic L-amino acids, such as L-dopa, L-tryptophan, and L-phenylalanine, to produce corresponding neurotransmitters or biogenic amines, including dopamine, serotonin, and histamine, respectively.

There are two main types of ALADs in humans: dopa decarboxylase (DDC) and tryptophan hydroxylase (TPH). DDC is responsible for the conversion of L-dopa to dopamine, which is a crucial neurotransmitter involved in movement regulation. TPH, on the other hand, catalyzes the rate-limiting step in serotonin synthesis by converting L-tryptophan to 5-hydroxytryptophan (5-HTP), which is then converted to serotonin by another enzyme called aromatic amino acid decarboxylase.

Deficiencies or mutations in ALADs can lead to various neurological and psychiatric disorders, such as Parkinson's disease, dopa-responsive dystonia, and depression. Therefore, understanding the function and regulation of ALADs is essential for developing effective therapies for these conditions.

Carboxy-lyases are a class of enzymes that catalyze the removal of a carboxyl group from a substrate, often releasing carbon dioxide in the process. These enzymes play important roles in various metabolic pathways, such as the biosynthesis and degradation of amino acids, sugars, and other organic compounds.

Carboxy-lyases are classified under EC number 4.2 in the Enzyme Commission (EC) system. They can be further divided into several subclasses based on their specific mechanisms and substrates. For example, some carboxy-lyases require a cofactor such as biotin or thiamine pyrophosphate to facilitate the decarboxylation reaction, while others do not.

Examples of carboxy-lyases include:

1. Pyruvate decarboxylase: This enzyme catalyzes the conversion of pyruvate to acetaldehyde and carbon dioxide during fermentation in yeast and other organisms.
2. Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO): This enzyme is essential for photosynthesis in plants and some bacteria, as it catalyzes the fixation of carbon dioxide into an organic molecule during the Calvin cycle.
3. Phosphoenolpyruvate carboxylase: Found in plants, algae, and some bacteria, this enzyme plays a role in anaplerotic reactions that replenish intermediates in the citric acid cycle. It catalyzes the conversion of phosphoenolpyruvate to oxaloacetate and inorganic phosphate.
4. Aspartate transcarbamylase: This enzyme is involved in the biosynthesis of pyrimidines, a class of nucleotides. It catalyzes the transfer of a carboxyl group from carbamoyl aspartate to carbamoyl phosphate, forming cytidine triphosphate (CTP) and fumarate.
5. Urocanase: Found in animals, this enzyme is involved in histidine catabolism. It catalyzes the conversion of urocanate to formiminoglutamate and ammonia.

Dopa decarboxylase (DDC) is an enzyme that plays a crucial role in the synthesis of dopamine and serotonin, two important neurotransmitters in the human body. This enzyme is responsible for converting levodopa (L-DOPA), an amino acid precursor, into dopamine, a critical neurotransmitter involved in movement regulation, motivation, reward, and mood.

The gene that encodes dopa decarboxylase is DDC, located on chromosome 7p12.2-p12.1. The enzyme is widely expressed throughout the body, including the brain, kidneys, liver, and gut. In addition to its role in neurotransmitter synthesis, dopa decarboxylase also contributes to the metabolism of certain drugs, such as levodopa and carbidopa, which are used in the treatment of Parkinson's disease.

Deficiencies or mutations in the DDC gene can lead to various neurological disorders, including aromatic L-amino acid decarboxylase deficiency (AADCD), a rare autosomal recessive disorder characterized by decreased levels of dopamine and serotonin. Symptoms of AADCD may include developmental delay, movement disorders, seizures, autonomic dysfunction, and oculogyric crises.

The amino acid transport system L is a type of membrane transport system that is responsible for the uptake of large neutral amino acids (LNAAs) into cells. This system is composed of several different proteins, including the light chain subunit LAT1 and the heavy chain subunit CD98hc, which form a heterodimer that functions as an amino acid transporter.

The transport system L primarily mediates the uptake of LNAAs such as leucine, isoleucine, valine, phenylalanine, tyrosine, and tryptophan into cells. It plays important roles in various physiological processes, including protein synthesis, neurotransmitter synthesis, and cell signaling.

The transport system L is also known as the L-type amino acid transporter (LAT) or the sodium-independent neutral amino acid transporter (SNAT). Mutations in genes encoding components of this transport system have been associated with various diseases, including neurological disorders and cancer.

Large Neutral Amino Acid-Transporter 1 (LAT1) is a type of transmembrane protein responsible for the transport of large neutral amino acids across the cell membrane. It is also known as SLC7A5, which is its official gene name according to the Human Genome Organization (HUGO). LAT1 forms a heterodimer with another protein called 4F2 heavy chain (4F2hc) or SLC3A2, and this complex is located on the plasma membrane.

LAT1 transports large neutral amino acids such as leucine, isoleucine, valine, phenylalanine, tyrosine, tryptophan, and methionine, as well as several drugs and toxins. It has a high affinity for these amino acids and plays an essential role in their uptake into cells. LAT1 is widely expressed in various tissues, including the brain, placenta, skeletal muscle, heart, liver, kidney, and pancreas.

In the brain, LAT1 is responsible for the transport of large neutral amino acids across the blood-brain barrier (BBB), which is crucial for maintaining brain function. Dysregulation of LAT1 has been implicated in several diseases, including cancer, epilepsy, and neurodegenerative disorders.

CD98 light chains are a type of cell surface protein found on many different types of cells in the body. They are part of a larger complex called CD98, which also includes a heavy chain component. Together, these proteins play a role in various cellular processes, including amino acid transport and cell-cell adhesion.

As antigens, CD98 light chains can be recognized by the immune system and may elicit an immune response. Antigens are typically foreign substances that invade the body and trigger an immune response, but self-antigens like CD98 light chains can also be targeted in certain autoimmune diseases or conditions where the immune system mistakenly attacks the body's own tissues.

CD98 light chains have been implicated in various disease processes, including cancer and autoimmune disorders. For example, some studies have suggested that high levels of CD98 expression may be associated with more aggressive tumor behavior and worse prognosis in certain types of cancer. Additionally, abnormalities in CD98 regulation have been linked to the development of autoimmune diseases like rheumatoid arthritis and multiple sclerosis.

Overall, while CD98 light chains are an important component of normal cellular function, their dysregulation or aberrant expression can contribute to various disease processes and may represent a potential target for therapeutic intervention in certain conditions.

Cyclic amino acids are a type of modified amino acid where the side chain of the amino acid forms a ring structure. This is different from the typical structure of amino acids, which have a linear side chain. The formation of the ring can occur within the same amino acid molecule or between two amino acid molecules.

Cyclic amino acids play important roles in various biological processes. For example, some cyclic amino acids are involved in the structure and function of proteins, while others serve as signaling molecules or neurotransmitters. Some common examples of cyclic amino acids include proline, hydroxyproline, and sarcosine.

It is worth noting that not all modified amino acids with ring structures are considered cyclic amino acids. For example, some amino acids may have a sulfur atom in their side chain that forms a disulfide bond with another cysteine residue, but this is not considered a cyclic structure because the ring is formed between two separate molecules rather than within a single molecule.

Glutamate decarboxylase (GAD) is an enzyme that plays a crucial role in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. GABA is an inhibitory neurotransmitter that helps to balance the excitatory effects of glutamate, another neurotransmitter.

Glutamate decarboxylase catalyzes the conversion of glutamate to GABA by removing a carboxyl group from the glutamate molecule. This reaction occurs in two steps, with the enzyme first converting glutamate to glutamic acid semialdehyde and then converting that intermediate product to GABA.

There are two major isoforms of glutamate decarboxylase, GAD65 and GAD67, which differ in their molecular weight, subcellular localization, and function. GAD65 is primarily responsible for the synthesis of GABA in neuronal synapses, while GAD67 is responsible for the synthesis of GABA in the cell body and dendrites of neurons.

Glutamate decarboxylase is an important target for research in neurology and psychiatry because dysregulation of GABAergic neurotransmission has been implicated in a variety of neurological and psychiatric disorders, including epilepsy, anxiety, depression, and schizophrenia.

CD98, also known as 4F2 cell surface antigen or solute carrier family 3 member 2 (SLC3A2), is a heterodimeric amino acid transporter protein. It is composed of two subunits: a heavy chain (CD98hc) and a light chain (4F2hc). CD98 is widely expressed in various tissues, including hematopoietic cells, endothelial cells, and epithelial cells.

As an antigen, CD98 can be recognized by specific antibodies and play a role in immune responses. The protein is involved in several biological processes, such as cell proliferation, differentiation, adhesion, and migration. It also functions as a receptor for certain viruses, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV).

CD98 has been implicated in various diseases, including cancer, autoimmune disorders, and infectious diseases. In cancer, CD98 overexpression has been associated with poor prognosis and resistance to chemotherapy. In autoimmune disorders, CD98 may contribute to the pathogenesis of diseases such as rheumatoid arthritis and multiple sclerosis. In infectious diseases, CD98 can serve as a target for viral entry and replication.

Overall, CD98 is a multifunctional protein that plays important roles in various physiological and pathological processes, making it an attractive target for therapeutic interventions.

Amino acid transport systems refer to the various membrane transport proteins that are responsible for the active or passive translocation of amino acids across cell membranes in the body. These transport systems play a crucial role in maintaining amino acid homeostasis within cells and regulating their availability for protein synthesis, neurotransmission, and other physiological processes.

There are several distinct amino acid transport systems, each with its own specificity for particular types of amino acids or related molecules. These systems can be classified based on their energy requirements, substrate specificity, and membrane localization. Some of the major amino acid transport systems include:

1. System A - This is a sodium-dependent transport system that primarily transports small, neutral amino acids such as alanine, serine, and proline. It has several subtypes (ASC, A, and AN) with different substrate affinities and kinetic properties.
2. System L - This is a sodium-independent transport system that transports large, neutral amino acids such as leucine, isoleucine, valine, phenylalanine, and tryptophan. It has several subtypes (L1, L2, and y+L) with different substrate specificities and transport mechanisms.
3. System B0 - This is a sodium-dependent transport system that transports both neutral and basic amino acids such as arginine, lysine, and ornithine. It has several subtypes (B0,+, B0-, and b0,+) with different substrate affinities and kinetic properties.
4. System y+ - This is a sodium-independent transport system that transports primarily basic amino acids such as arginine, lysine, and ornithine. It has several subtypes (y+L, y+, b0,+) with different substrate specificities and transport mechanisms.
5. System X-AG - This is a sodium-independent antiporter system that exchanges glutamate and aspartate for neutral amino acids such as cystine, serine, and threonine. It plays an essential role in maintaining redox homeostasis by regulating the intracellular levels of cysteine, a precursor of glutathione.

These transport systems are critical for maintaining cellular homeostasis and regulating various physiological processes such as protein synthesis, neurotransmission, and immune function. Dysregulation of these transport systems has been implicated in several diseases, including cancer, neurological disorders, and cardiovascular disease. Therefore, understanding the molecular mechanisms underlying these transport systems is essential for developing novel therapeutic strategies to treat these conditions.

Amino acids are organic compounds that serve as the building blocks of proteins. They consist of a central carbon atom, also known as the alpha carbon, which is bonded to an amino group (-NH2), a carboxyl group (-COOH), a hydrogen atom (H), and a variable side chain (R group). The R group can be composed of various combinations of atoms such as hydrogen, oxygen, sulfur, nitrogen, and carbon, which determine the unique properties of each amino acid.

There are 20 standard amino acids that are encoded by the genetic code and incorporated into proteins during translation. These include:

1. Alanine (Ala)
2. Arginine (Arg)
3. Asparagine (Asn)
4. Aspartic acid (Asp)
5. Cysteine (Cys)
6. Glutamine (Gln)
7. Glutamic acid (Glu)
8. Glycine (Gly)
9. Histidine (His)
10. Isoleucine (Ile)
11. Leucine (Leu)
12. Lysine (Lys)
13. Methionine (Met)
14. Phenylalanine (Phe)
15. Proline (Pro)
16. Serine (Ser)
17. Threonine (Thr)
18. Tryptophan (Trp)
19. Tyrosine (Tyr)
20. Valine (Val)

Additionally, there are several non-standard or modified amino acids that can be incorporated into proteins through post-translational modifications, such as hydroxylation, methylation, and phosphorylation. These modifications expand the functional diversity of proteins and play crucial roles in various cellular processes.

Amino acids are essential for numerous biological functions, including protein synthesis, enzyme catalysis, neurotransmitter production, energy metabolism, and immune response regulation. Some amino acids can be synthesized by the human body (non-essential), while others must be obtained through dietary sources (essential).

CD98 heavy chain is a type of protein found on the surface of many different types of cells in the human body. It is also known as SLCA1 or 4F2hc. The CD98 heavy chain combines with various other proteins to form transporter proteins, which are involved in the transport of various molecules across the cell membrane.

In the context of immunology and medical terminology, antigens are substances (usually proteins) on the surface of cells, viruses, fungi, or bacteria that can be recognized by the immune system and stimulate an immune response. The CD98 heavy chain is not typically referred to as an antigen itself, but it may contribute to the overall antigenic properties of the cell expressing it.

However, it's important to note that the term "CD98 Heavy Chain" refers to a specific protein and not a medical condition or disease. If you have any specific concerns about this protein or its role in health and disease, I would recommend consulting with a healthcare professional or a researcher in the field of immunology.

The amino acid transport system y+ is a type of sodium-independent cationic amino acid transporter that is responsible for the uptake of positively charged amino acids, such as arginine and lysine, into cells. It is a part of a larger family of amino acid transporters that are involved in the transport of various types of amino acids across cell membranes.

The y+ system is composed of several different transporter proteins, including rBAT/4F2hc heteromeric amino acid transporter (Cat1), and light chains such as y+LAT1, y+LAT2, and y+LAT3. These transporters are widely expressed in various tissues, including the small intestine, kidney, liver, and brain.

The y+ system plays important roles in various physiological processes, including protein synthesis, immune function, and neurotransmitter metabolism. Dysregulation of this transport system has been implicated in several diseases, such as cancer, neurological disorders, and kidney disease.

Leucine is an essential amino acid, meaning it cannot be produced by the human body and must be obtained through the diet. It is one of the three branched-chain amino acids (BCAAs), along with isoleucine and valine. Leucine is critical for protein synthesis and muscle growth, and it helps to regulate blood sugar levels, promote wound healing, and produce growth hormones.

Leucine is found in various food sources such as meat, dairy products, eggs, and certain plant-based proteins like soy and beans. It is also available as a dietary supplement for those looking to increase their intake for athletic performance or muscle recovery purposes. However, it's important to consult with a healthcare professional before starting any new supplement regimen.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Histidine Decarboxylase is a medical term that refers to an enzyme found in various organisms, including humans. This enzyme plays a crucial role in the conversion of the amino acid L-histidine into histamine, which is a biogenic amine that acts as a neurotransmitter and inflammatory mediator in the human body.

Histidine decarboxylase is found in several tissues, including the central nervous system, gastrointestinal tract, and skin. It requires pyridoxal 5'-phosphate (PLP) as a cofactor for its enzymatic activity. Abnormal levels or activity of histidine decarboxylase have been implicated in several medical conditions, including allergic reactions, inflammation, and neuropsychiatric disorders.

Inhibitors of histidine decarboxylase are being investigated as potential therapeutic agents for the treatment of various diseases, such as mast cell-mediated disorders, gastrointestinal disorders, and neurological conditions associated with abnormal histamine levels.

Pyruvate decarboxylase is an enzyme that plays a crucial role in the cellular process of fermentation and gluconeogenesis. In medical and biochemical terms, pyruvate decarboxylase is defined as:

"An enzyme (EC 4.1.1.1) that catalyzes the decarboxylation of pyruvate to form acetaldehyde and carbon dioxide in the presence of thiamine pyrophosphate (TPP) as a cofactor. This reaction occurs during anaerobic metabolism, such as alcohol fermentation in yeast or bacteria, and helps to generate ATP and NADH for the cell's energy needs."

In humans, pyruvate decarboxylase is primarily found in the liver and kidneys, where it participates in gluconeogenesis – the process of generating new glucose molecules from non-carbohydrate precursors. The enzyme's activity is essential for maintaining blood glucose levels during fasting or low-carbohydrate intake.

Deficiencies in pyruvate decarboxylase can lead to metabolic disorders, such as pyruvate decarboxylase deficiency (PDC deficiency), which is characterized by lactic acidosis, developmental delays, and neurological issues. Proper diagnosis and management of these conditions often involve monitoring enzyme activity and glucose metabolism.

Stereoisomerism is a type of isomerism (structural arrangement of atoms) in which molecules have the same molecular formula and sequence of bonded atoms, but differ in the three-dimensional orientation of their atoms in space. This occurs when the molecule contains asymmetric carbon atoms or other rigid structures that prevent free rotation, leading to distinct spatial arrangements of groups of atoms around a central point. Stereoisomers can have different chemical and physical properties, such as optical activity, boiling points, and reactivities, due to differences in their shape and the way they interact with other molecules.

There are two main types of stereoisomerism: enantiomers (mirror-image isomers) and diastereomers (non-mirror-image isomers). Enantiomers are pairs of stereoisomers that are mirror images of each other, but cannot be superimposed on one another. Diastereomers, on the other hand, are non-mirror-image stereoisomers that have different physical and chemical properties.

Stereoisomerism is an important concept in chemistry and biology, as it can affect the biological activity of molecules, such as drugs and natural products. For example, some enantiomers of a drug may be active, while others are inactive or even toxic. Therefore, understanding stereoisomerism is crucial for designing and synthesizing effective and safe drugs.

Decarboxylation is a chemical reaction that removes a carboxyl group from a molecule and releases carbon dioxide (CO2) as a result. In the context of medical chemistry, decarboxylation is a crucial process in the activation of certain acidic precursor compounds into their biologically active forms.

For instance, when discussing phytocannabinoids found in cannabis plants, decarboxylation converts non-psychoactive tetrahydrocannabinolic acid (THCA) into psychoactive delta-9-tetrahydrocannabinol (Δ9-THC) through the removal of a carboxyl group. This reaction typically occurs when the plant material is exposed to heat, such as during smoking or vaporization, or when it undergoes aging.

In summary, decarboxylation refers to the chemical process that removes a carboxyl group from a molecule and releases CO2, which can activate certain acidic precursor compounds into their biologically active forms in medical chemistry.

Sequence homology, amino acid, refers to the similarity in the order of amino acids in a protein or a portion of a protein between two or more species. This similarity can be used to infer evolutionary relationships and functional similarities between proteins. The higher the degree of sequence homology, the more likely it is that the proteins are related and have similar functions. Sequence homology can be determined through various methods such as pairwise alignment or multiple sequence alignment, which compare the sequences and calculate a score based on the number and type of matching amino acids.

Aromatic amino acids are a specific type of amino acids that contain an aromatic ring in their side chain. The three aromatic amino acids are phenylalanine (Phe), tyrosine (Tyr), and tryptophan (Trp). These amino acids play important roles in various biological processes, including protein structure and function, neurotransmission, and enzyme catalysis.

The aromatic ring in these amino acids is composed of a planar six-membered carbon ring that contains alternating double bonds. This structure gives the side chains unique chemical properties, such as their ability to absorb ultraviolet light and participate in stacking interactions with other aromatic residues. These interactions can contribute to the stability and function of proteins and other biological molecules.

It's worth noting that while most amino acids are classified as either "hydrophobic" or "hydrophilic," depending on their chemical properties, aromatic amino acids exhibit characteristics of both groups. They can form hydrogen bonds with polar residues and also engage in hydrophobic interactions with nonpolar residues, making them versatile building blocks for protein structure and function.

Ornithine decarboxylase (ODC) is a medical/biochemical term that refers to an enzyme (EC 4.1.1.17) involved in the metabolism of amino acids, particularly ornithine. This enzyme catalyzes the decarboxylation of ornithine to form putrescine, which is a precursor for the synthesis of polyamines, such as spermidine and spermine. Polyamines play crucial roles in various cellular processes, including cell growth, differentiation, and gene expression.

Ornithine decarboxylase is a rate-limiting enzyme in polyamine biosynthesis, meaning that its activity regulates the overall production of these molecules. The regulation of ODC activity is tightly controlled at multiple levels, including transcription, translation, and post-translational modifications. Dysregulation of ODC activity has been implicated in several pathological conditions, such as cancer, neurodegenerative disorders, and inflammatory diseases.

Inhibitors of ornithine decarboxylase have been explored as potential therapeutic agents for various diseases, including cancer, due to their ability to suppress polyamine synthesis and cell proliferation. However, the use of ODC inhibitors in clinical settings has faced challenges related to toxicity and limited efficacy.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Adenosylmethionine decarboxylase (AdoMetDC) is an enzyme that plays a crucial role in the biosynthesis of polyamines, which are essential molecules for cell growth and differentiation. The enzyme catalyzes the decarboxylation of S-adenosylmethionine (SAM) to produce decarboxylated SAM, also known as deoxyadenosylcobalamin or coenzyme M.

Decarboxylated SAM serves as an aminopropyl group donor in the biosynthesis of polyamines such as spermidine and spermine. These polyamines are involved in various cellular processes, including DNA replication, transcription, translation, protein synthesis, and cell signaling.

AdoMetDC is a pyridoxal-5'-phosphate (PLP)-dependent enzyme that requires the cofactor vitamin B12 for its activity. It is found in various organisms, including bacteria, yeast, plants, and animals. In humans, AdoMetDC is encoded by the AMD1 gene and is localized mainly in the cytosol of cells.

Dysregulation of AdoMetDC activity has been implicated in several diseases, such as cancer, neurodegenerative disorders, and cardiovascular diseases. Therefore, targeting AdoMetDC with inhibitors or activators has emerged as a potential therapeutic strategy for treating these conditions.

Aromatic hydrocarbons, also known as aromatic compounds or arenes, are a class of organic compounds characterized by a planar ring structure with delocalized electrons that give them unique chemical properties. The term "aromatic" was originally used to describe their distinctive odors, but it now refers to their characteristic molecular structure and stability.

Aromatic hydrocarbons contain one or more benzene rings, which are cyclic structures consisting of six carbon atoms arranged in a planar hexagonal shape. Each carbon atom in the benzene ring is bonded to two other carbon atoms and one hydrogen atom, forming alternating double and single bonds between the carbon atoms. However, the delocalized electrons in the benzene ring are evenly distributed around the ring, leading to a unique electronic structure that imparts stability and distinctive chemical properties to aromatic hydrocarbons.

Examples of aromatic hydrocarbons include benzene, toluene, xylene, and naphthalene. These compounds have important uses in industry, but they can also pose health risks if not handled properly. Exposure to high levels of aromatic hydrocarbons has been linked to various health effects, including cancer, neurological damage, and respiratory problems.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Selenomonas is a genus of gram-negative, anaerobic bacteria that are commonly found in the oral cavity and gastrointestinal tract of humans and animals. These bacteria have a unique characteristic of having curved or spiral-shaped morphology and a polar flagellum for motility. They are named after their ability to reduce selenite to elemental selenium, which gives them a characteristic red color.

Selenomonas species are often associated with dental caries and periodontal disease due to their production of acid and other virulence factors that can contribute to tissue destruction. However, they also play important roles in the breakdown of complex carbohydrates and the production of volatile sulfur compounds in the gut.

It's worth noting that while Selenomonas species are generally considered to be commensal organisms, they have been implicated in various opportunistic infections, particularly in immunocompromised individuals or those with underlying medical conditions.

Pyridoxal phosphate (PLP) is the active form of vitamin B6 and functions as a cofactor in various enzymatic reactions in the human body. It plays a crucial role in the metabolism of amino acids, carbohydrates, lipids, and neurotransmitters. Pyridoxal phosphate is involved in more than 140 different enzyme-catalyzed reactions, making it one of the most versatile cofactors in human biochemistry.

As a cofactor, pyridoxal phosphate helps enzymes carry out their functions by facilitating chemical transformations in substrates (the molecules on which enzymes act). In particular, PLP is essential for transamination, decarboxylation, racemization, and elimination reactions involving amino acids. These processes are vital for the synthesis and degradation of amino acids, neurotransmitters, hemoglobin, and other crucial molecules in the body.

Pyridoxal phosphate is formed from the conversion of pyridoxal (a form of vitamin B6) by the enzyme pyridoxal kinase, using ATP as a phosphate donor. The human body obtains vitamin B6 through dietary sources such as whole grains, legumes, vegetables, nuts, and animal products like poultry, fish, and pork. It is essential to maintain adequate levels of pyridoxal phosphate for optimal enzymatic function and overall health.

An amino acid substitution is a type of mutation in which one amino acid in a protein is replaced by another. This occurs when there is a change in the DNA sequence that codes for a particular amino acid in a protein. The genetic code is redundant, meaning that most amino acids are encoded by more than one codon (a sequence of three nucleotides). As a result, a single base pair change in the DNA sequence may not necessarily lead to an amino acid substitution. However, if a change does occur, it can have a variety of effects on the protein's structure and function, depending on the nature of the substituted amino acids. Some substitutions may be harmless, while others may alter the protein's activity or stability, leading to disease.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

In genetics, sequence alignment is the process of arranging two or more DNA, RNA, or protein sequences to identify regions of similarity or homology between them. This is often done using computational methods to compare the nucleotide or amino acid sequences and identify matching patterns, which can provide insight into evolutionary relationships, functional domains, or potential genetic disorders. The alignment process typically involves adjusting gaps and mismatches in the sequences to maximize the similarity between them, resulting in an aligned sequence that can be visually represented and analyzed.

Polyporales is an order of class Agaricomycetes, division Basidiomycota, in the kingdom Fungi. This order consists of various wood-decay fungi, characterized by their typically annual growth rings and pores on the underside of the cap. The fruiting bodies or conks of these fungi can be either resupinate (crust-like) or pileate (cap-like). Polyporales includes several economically important species that cause decay in trees and timber, as well as some medicinal mushrooms. Examples of genera within this order include Polyporus, Trametes, Fomes, and Ganoderma.

Putrescine is an organic compound with the chemical formula NH2(CH2)4NH2. It is a colorless, viscous liquid that is produced by the breakdown of amino acids in living organisms and is often associated with putrefaction, hence its name. Putrescine is a type of polyamine, which is a class of organic compounds that contain multiple amino groups.

Putrescine is produced in the body through the decarboxylation of the amino acid ornithine by the enzyme ornithine decarboxylase. It is involved in various cellular processes, including the regulation of gene expression and cell growth. However, at high concentrations, putrescine can be toxic to cells and has been implicated in the development of certain diseases, such as cancer.

Putrescine is also found in various foods, including meats, fish, and some fruits and vegetables. It contributes to the unpleasant odor that develops during spoilage, which is why putrescine is often used as an indicator of food quality and safety.

Thiamine pyrophosphate (TPP) is the active form of thiamine (vitamin B1) that plays a crucial role as a cofactor in various enzymatic reactions, particularly in carbohydrate metabolism. TPP is essential for the functioning of three key enzymes: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase. These enzymes are involved in critical processes such as the conversion of pyruvate to acetyl-CoA, the oxidative decarboxylation of alpha-ketoglutarate in the Krebs cycle, and the pentose phosphate pathway, which is important for generating reducing equivalents (NADPH) and ribose sugars for nucleotide synthesis. A deficiency in thiamine or TPP can lead to severe neurological disorders, including beriberi and Wernicke-Korsakoff syndrome, which are often observed in alcoholics due to poor nutrition and impaired thiamine absorption.

Ornithine is not a medical condition but a naturally occurring alpha-amino acid, which is involved in the urea cycle, a process that eliminates ammonia from the body. Here's a brief medical/biochemical definition of Ornithine:

Ornithine (NH₂-CH₂-CH₂-CH(NH₃)-COOH) is an α-amino acid without a carbon atom attached to the amino group, classified as a non-proteinogenic amino acid because it is not encoded by the standard genetic code and not commonly found in proteins. It plays a crucial role in the urea cycle, where it helps convert harmful ammonia into urea, which can then be excreted by the body through urine. Ornithine is produced from the breakdown of arginine, another amino acid, via the enzyme arginase. In some medical and nutritional contexts, ornithine supplementation may be recommended to support liver function, wound healing, or muscle growth, but its effectiveness for these uses remains a subject of ongoing research and debate.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Polyamines are organic compounds with more than one amino group (-NH2) and at least one carbon atom bonded to two or more amino groups. They are found in various tissues and fluids of living organisms and play important roles in many biological processes, such as cell growth, differentiation, and apoptosis (programmed cell death). Polyamines are also involved in the regulation of ion channels and transporters, DNA replication and gene expression. The most common polyamines found in mammalian cells are putrescine, spermidine, and spermine. They are derived from the decarboxylation of amino acids such as ornithine and methionine. Abnormal levels of polyamines have been associated with various pathological conditions, including cancer and neurodegenerative diseases.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Cadaverine is a foul-smelling organic compound that is produced by the breakdown of certain amino acids in dead bodies. It is formed through the decarboxylation of lysine, an essential amino acid, and is characterized by its strong, unpleasant odor. Cadaverine is often used as a forensic indicator of decomposition and is also being studied for its potential role in various physiological processes, such as inflammation and cancer.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Essential amino acids are a group of 9 out of the 20 standard amino acids that cannot be synthesized by the human body and must be obtained through diet. They include: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. These amino acids are essential for various biological processes such as protein synthesis, growth, and repair of body tissues. A deficiency in any of these essential amino acids can lead to impaired physical development and compromised immune function. Foods that provide all nine essential amino acids are considered complete proteins and include animal-derived products like meat, poultry, fish, eggs, and dairy, as well as soy and quinoa.

Tricarboxylic acids, also known as TCA cycle or citric acid cycle, is a series of chemical reactions used by all living cells to generate energy through the oxidation of acetyl-CoA derived from carbohydrates, fats, and proteins into carbon dioxide and water in the form of ATP. This process is an important part of cellular respiration and occurs in the mitochondria. The cycle involves eight steps that result in the production of two molecules of ATP, reduced coenzymes NADH and FADH2, and the release of three molecules of carbon dioxide.

The tricarboxylic acids involved in this cycle are:

1. Citric acid (also known as citrate)
2. Cis-aconitic acid
3. Isocitric acid
4. Oxalosuccinic acid (an intermediate that is not regenerated)
5. α-Ketoglutaric acid (also known as alpha-ketoglutarate)
6. Succinyl-CoA
7. Succinic acid (also known as succinate)
8. Fumaric acid
9. Malic acid
10. Oxaloacetic acid (also known as oxalacetate)

These acids play a crucial role in the energy production and metabolism of living organisms.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

Pyruvic acid, also known as 2-oxopropanoic acid, is a key metabolic intermediate in both anaerobic and aerobic respiration. It is a carboxylic acid with a ketone functional group, making it a β-ketoacid. In the cytosol, pyruvate is produced from glucose during glycolysis, where it serves as a crucial link between the anaerobic breakdown of glucose and the aerobic process of cellular respiration in the mitochondria.

During low oxygen availability or high energy demands, pyruvate can be converted into lactate through anaerobic glycolysis, allowing for the continued production of ATP (adenosine triphosphate) without oxygen. In the presence of adequate oxygen and functional mitochondria, pyruvate is transported into the mitochondrial matrix where it undergoes oxidative decarboxylation to form acetyl-CoA by the enzyme pyruvate dehydrogenase complex (PDC). This reaction also involves the reduction of NAD+ to NADH and the release of CO2. Acetyl-CoA then enters the citric acid cycle, where it is further oxidized to produce energy in the form of ATP, NADH, FADH2, and GTP (guanosine triphosphate) through a series of enzymatic reactions.

In summary, pyruvic acid is a vital metabolic intermediate that plays a significant role in energy production pathways, connecting glycolysis to both anaerobic and aerobic respiration.

Amino acid motifs are recurring patterns or sequences of amino acids in a protein molecule. These motifs can be identified through various sequence analysis techniques and often have functional or structural significance. They can be as short as two amino acids in length, but typically contain at least three to five residues.

Some common examples of amino acid motifs include:

1. Active site motifs: These are specific sequences of amino acids that form the active site of an enzyme and participate in catalyzing chemical reactions. For example, the catalytic triad in serine proteases consists of three residues (serine, histidine, and aspartate) that work together to hydrolyze peptide bonds.
2. Signal peptide motifs: These are sequences of amino acids that target proteins for secretion or localization to specific organelles within the cell. For example, a typical signal peptide consists of a positively charged n-region, a hydrophobic h-region, and a polar c-region that directs the protein to the endoplasmic reticulum membrane for translocation.
3. Zinc finger motifs: These are structural domains that contain conserved sequences of amino acids that bind zinc ions and play important roles in DNA recognition and regulation of gene expression.
4. Transmembrane motifs: These are sequences of hydrophobic amino acids that span the lipid bilayer of cell membranes and anchor transmembrane proteins in place.
5. Phosphorylation sites: These are specific serine, threonine, or tyrosine residues that can be phosphorylated by protein kinases to regulate protein function.

Understanding amino acid motifs is important for predicting protein structure and function, as well as for identifying potential drug targets in disease-associated proteins.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

X-ray crystallography is a technique used in structural biology to determine the three-dimensional arrangement of atoms in a crystal lattice. In this method, a beam of X-rays is directed at a crystal and diffracts, or spreads out, into a pattern of spots called reflections. The intensity and angle of each reflection are measured and used to create an electron density map, which reveals the position and type of atoms in the crystal. This information can be used to determine the molecular structure of a compound, including its shape, size, and chemical bonds. X-ray crystallography is a powerful tool for understanding the structure and function of biological macromolecules such as proteins and nucleic acids.

Site-directed mutagenesis is a molecular biology technique used to introduce specific and targeted changes to a specific DNA sequence. This process involves creating a new variant of a gene or a specific region of interest within a DNA molecule by introducing a planned, deliberate change, or mutation, at a predetermined site within the DNA sequence.

The methodology typically involves the use of molecular tools such as PCR (polymerase chain reaction), restriction enzymes, and/or ligases to introduce the desired mutation(s) into a plasmid or other vector containing the target DNA sequence. The resulting modified DNA molecule can then be used to transform host cells, allowing for the production of large quantities of the mutated gene or protein for further study.

Site-directed mutagenesis is a valuable tool in basic research, drug discovery, and biotechnology applications where specific changes to a DNA sequence are required to understand gene function, investigate protein structure/function relationships, or engineer novel biological properties into existing genes or proteins.

Histidine is an essential amino acid, meaning it cannot be synthesized by the human body and must be obtained through dietary sources. Its chemical formula is C6H9N3O2. Histidine plays a crucial role in several physiological processes, including:

1. Protein synthesis: As an essential amino acid, histidine is required for the production of proteins, which are vital components of various tissues and organs in the body.

2. Hemoglobin synthesis: Histidine is a key component of hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. The imidazole side chain of histidine acts as a proton acceptor/donor, facilitating the release and uptake of oxygen by hemoglobin.

3. Acid-base balance: Histidine is involved in maintaining acid-base homeostasis through its role in the biosynthesis of histamine, which is a critical mediator of inflammatory responses and allergies. The decarboxylation of histidine results in the formation of histamine, which can increase vascular permeability and modulate immune responses.

4. Metal ion binding: Histidine has a high affinity for metal ions such as zinc, copper, and iron. This property allows histidine to participate in various enzymatic reactions and maintain the structural integrity of proteins.

5. Antioxidant defense: Histidine-containing dipeptides, like carnosine and anserine, have been shown to exhibit antioxidant properties by scavenging reactive oxygen species (ROS) and chelating metal ions. These compounds may contribute to the protection of proteins and DNA from oxidative damage.

Dietary sources of histidine include meat, poultry, fish, dairy products, and wheat germ. Histidine deficiency is rare but can lead to growth retardation, anemia, and impaired immune function.

Lactobacillus is a genus of gram-positive, rod-shaped, facultatively anaerobic or microaerophilic, non-spore-forming bacteria. They are part of the normal flora found in the intestinal, urinary, and genital tracts of humans and other animals. Lactobacilli are also commonly found in some fermented foods, such as yogurt, sauerkraut, and sourdough bread.

Lactobacilli are known for their ability to produce lactic acid through the fermentation of sugars, which contributes to their role in maintaining a healthy microbiota and lowering the pH in various environments. Some species of Lactobacillus have been shown to provide health benefits, such as improving digestion, enhancing immune function, and preventing infections, particularly in the urogenital and intestinal tracts. They are often used as probiotics, either in food or supplement form, to promote a balanced microbiome and support overall health.

Hydrogen-ion concentration, also known as pH, is a measure of the acidity or basicity of a solution. It is defined as the negative logarithm (to the base 10) of the hydrogen ion activity in a solution. The standard unit of measurement is the pH unit. A pH of 7 is neutral, less than 7 is acidic, and greater than 7 is basic.

In medical terms, hydrogen-ion concentration is important for maintaining homeostasis within the body. For example, in the stomach, a high hydrogen-ion concentration (low pH) is necessary for the digestion of food. However, in other parts of the body such as blood, a high hydrogen-ion concentration can be harmful and lead to acidosis. Conversely, a low hydrogen-ion concentration (high pH) in the blood can lead to alkalosis. Both acidosis and alkalosis can have serious consequences on various organ systems if not corrected.

A Structure-Activity Relationship (SAR) in the context of medicinal chemistry and pharmacology refers to the relationship between the chemical structure of a drug or molecule and its biological activity or effect on a target protein, cell, or organism. SAR studies aim to identify patterns and correlations between structural features of a compound and its ability to interact with a specific biological target, leading to a desired therapeutic response or undesired side effects.

By analyzing the SAR, researchers can optimize the chemical structure of lead compounds to enhance their potency, selectivity, safety, and pharmacokinetic properties, ultimately guiding the design and development of novel drugs with improved efficacy and reduced toxicity.

Medical definitions typically focus on the relevance of a term to medicine or healthcare, so here's a medical perspective on polycyclic compounds:

Polycyclic compounds are organic substances that contain two or more chemical rings in their structure. While not all polycyclic compounds are relevant to medicine, some can have significant medical implications. For instance, polycyclic aromatic hydrocarbons (PAHs) are a type of polycyclic compound that can be found in tobacco smoke and certain types of air pollution. PAHs have been linked to an increased risk of cancer, particularly lung cancer, due to their ability to damage DNA.

Another example is the class of drugs called steroids, which include hormones like cortisol and sex hormones like testosterone and estrogen. These compounds are polycyclic because they contain several interconnected rings in their structure. Steroid medications are used to treat a variety of medical conditions, including inflammation, asthma, and Addison's disease.

In summary, while not all polycyclic compounds are relevant to medicine, some can have important medical implications, either as harmful environmental pollutants or as useful therapeutic agents.

Catalysis is the process of increasing the rate of a chemical reaction by adding a substance known as a catalyst, which remains unchanged at the end of the reaction. A catalyst lowers the activation energy required for the reaction to occur, thereby allowing the reaction to proceed more quickly and efficiently. This can be particularly important in biological systems, where enzymes act as catalysts to speed up metabolic reactions that are essential for life.

"Pseudomonas" is a genus of Gram-negative, rod-shaped bacteria that are widely found in soil, water, and plants. Some species of Pseudomonas can cause disease in animals and humans, with P. aeruginosa being the most clinically relevant as it's an opportunistic pathogen capable of causing various types of infections, particularly in individuals with weakened immune systems.

P. aeruginosa is known for its remarkable ability to resist many antibiotics and disinfectants, making infections caused by this bacterium difficult to treat. It can cause a range of healthcare-associated infections, such as pneumonia, bloodstream infections, urinary tract infections, and surgical site infections. In addition, it can also cause external ear infections and eye infections.

Prompt identification and appropriate antimicrobial therapy are crucial for managing Pseudomonas infections, although the increasing antibiotic resistance poses a significant challenge in treatment.

Branched-chain amino acids (BCAAs) are a group of three essential amino acids: leucine, isoleucine, and valine. They are called "branched-chain" because of their chemical structure, which has a side chain that branches off from the main part of the molecule.

BCAAs are essential because they cannot be produced by the human body and must be obtained through diet or supplementation. They are crucial for muscle growth and repair, and play a role in energy production during exercise. BCAAs are also important for maintaining proper immune function and can help to reduce muscle soreness and fatigue after exercise.

Foods that are good sources of BCAAs include meat, poultry, fish, eggs, dairy products, and legumes. BCAAs are also available as dietary supplements, which are often used by athletes and bodybuilders to enhance muscle growth and recovery. However, it is important to note that excessive intake of BCAAs may have adverse effects on liver function and insulin sensitivity, so it is recommended to consult with a healthcare provider before starting any new supplement regimen.

Phenylalanine is an essential amino acid, meaning it cannot be produced by the human body and must be obtained through diet or supplementation. It's one of the building blocks of proteins and is necessary for the production of various molecules in the body, such as neurotransmitters (chemical messengers in the brain).

Phenylalanine has two forms: L-phenylalanine and D-phenylalanine. L-phenylalanine is the form found in proteins and is used by the body for protein synthesis, while D-phenylalanine has limited use in humans and is not involved in protein synthesis.

Individuals with a rare genetic disorder called phenylketonuria (PKU) must follow a low-phenylalanine diet or take special medical foods because they are unable to metabolize phenylalanine properly, leading to its buildup in the body and potential neurological damage.

Complementary DNA (cDNA) is a type of DNA that is synthesized from a single-stranded RNA molecule through the process of reverse transcription. In this process, the enzyme reverse transcriptase uses an RNA molecule as a template to synthesize a complementary DNA strand. The resulting cDNA is therefore complementary to the original RNA molecule and is a copy of its coding sequence, but it does not contain non-coding regions such as introns that are present in genomic DNA.

Complementary DNA is often used in molecular biology research to study gene expression, protein function, and other genetic phenomena. For example, cDNA can be used to create cDNA libraries, which are collections of cloned cDNA fragments that represent the expressed genes in a particular cell type or tissue. These libraries can then be screened for specific genes or gene products of interest. Additionally, cDNA can be used to produce recombinant proteins in heterologous expression systems, allowing researchers to study the structure and function of proteins that may be difficult to express or purify from their native sources.

'Acinetobacter' is a genus of gram-negative, aerobic bacteria that are commonly found in the environment, including water, soil, and healthcare settings. They are known for their ability to survive in a wide range of temperatures and pH levels, as well as their resistance to many antibiotics.

Some species of Acinetobacter can cause healthcare-associated infections, particularly in patients who are hospitalized, have weakened immune systems, or have been exposed to medical devices such as ventilators or catheters. These infections can include pneumonia, bloodstream infections, wound infections, and meningitis.

Acinetobacter baumannii is one of the most common species associated with human infection and is often resistant to multiple antibiotics, making it a significant public health concern. Infections caused by Acinetobacter can be difficult to treat and may require the use of last-resort antibiotics.

Preventing the spread of Acinetobacter in healthcare settings is important and includes practices such as hand hygiene, environmental cleaning, and contact precautions for patients with known or suspected infection.

Sequence homology in nucleic acids refers to the similarity or identity between the nucleotide sequences of two or more DNA or RNA molecules. It is often used as a measure of biological relationship between genes, organisms, or populations. High sequence homology suggests a recent common ancestry or functional constraint, while low sequence homology may indicate a more distant relationship or different functions.

Nucleic acid sequence homology can be determined by various methods such as pairwise alignment, multiple sequence alignment, and statistical analysis. The degree of homology is typically expressed as a percentage of identical or similar nucleotides in a given window of comparison.

It's important to note that the interpretation of sequence homology depends on the biological context and the evolutionary distance between the sequences compared. Therefore, functional and experimental validation is often necessary to confirm the significance of sequence homology.

... inhibitor, a class of anti-Parkinson drugs Aromatic amino acids Histidine decarboxylase PDB ... Aromatic L-amino acid decarboxylase (AADC or AAAD), also known as DOPA decarboxylase (DDC), tryptophan decarboxylase, and 5- ... Aromatic-L-Amino-Acid+Decarboxylases at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology ( ... Aromatic L-amino acid decarboxylase is active as a homodimer. Before addition of the pyridoxal phosphate cofactor, the ...
An aromatic L-amino acid decarboxylase inhibitor (synonyms: DOPA decarboxylase inhibitor, Extracerebral decarboxylase inhibitor ... v t e (CS1 German-language sources (de), Aromatic L-amino acid decarboxylase inhibitors, All stub articles, Nervous system drug ... medication of type enzyme inhibitor which inhibits the synthesis of dopamine by the enzyme aromatic L-amino acid decarboxylase ... "Editorial: Dopa decarboxylase inhibitors". British Medical Journal. 4 (5939): 250-1. November 1974. doi:10.1136/bmj.4.5939.250 ...
Other names in common use include L-phenylalanine decarboxylase, aromatic L-amino acid decarboxylase, and L-phenylalanine ... Schulz AR, Oliner L (1967). "The possible role of thyroid aromatic amino acid decarboxylase in thyroxine biosynthesis". Life ... Lovenberg W, Weissbach H, Udenfriend S (1962). "Aromatic L-amino acid decarboxylase". J. Biol. Chem. 237: 89-93. PMID 14466899 ... The enzyme phenylalanine decarboxylase (EC 4.1.1.53) catalyzes the chemical reaction L-phenylalanine ⇌ {\displaystyle \ ...
CYP19A1 Aromatic L-amino acid decarboxylase deficiency; 608643; DDC Arrhythmogenic right ventricular dysplasia 1; 107970; TGFB3 ... FREM1 Bile acid malabsorption, primary; 613291; SLC10A2 Bile acid synthesis defect, congenital, 2; 235555; AKR1D1 Bile acid ... SBDS Sialic acid storage disorder, infantile; 269920; SLC17A5 Sialidosis, type I; 256550; NEU1 Sialidosis, type II; 256550; ... SLC7A7 Lysosomal acid phosphatase deficiency; 200950; ACP2 Lysyl hydroxylase 3 deficiency; 612394; PLOD3 Machado-Joseph disease ...
EC 4.1.1.28 - Aromatic-L-amino-acid decarboxylase (Homo sapiens). July 2016. Retrieved 7 October 2016. Substrate: m-tyrosine ... meta-Tyramine is produced in humans via aromatic amino acid decarboxylase-mediated metabolism of meta-tyrosine. meta-Tyramine ...
... it is converted into dopamine by the enzyme aromatic l-amino acid decarboxylase, also known as DOPA decarboxylase. Pyridoxal ... Alpha-Amino acids, Aromatic amino acids, Antiparkinsonian agents, Carbonic anhydrase activators, Catecholamines, Dopamine ... Hyland K, Clayton PT (December 1992). "Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology" (PDF). Clinical ... Dopamine is formed by the decarboxylation of l-DOPA by aromatic l-amino acid decarboxylase (AADC). l-DOPA can be directly ...
"Eladocagene exuparvovec for aromatic l-amino acid decarboxylase deficiency". National Institute for Health and Care Research. ... Eladocagene exuparvovec is indicated for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency. Eladocagene ... intended for the treatment of aromatic L‑amino acid decarboxylase (AADC) deficiency. As Upstaza is an advanced therapy ... amino acid decarboxylase (AADC) deficiency. It infuses the gene encoding for the human AADC enzyme into the putamen region of ...
Aromatic L-amino acid decarboxylase (AADC) levels were at no time affected. It is used in scientific research in humans and ... Alpha-Amino acids, Amino acid derivatives, Chloroarenes, Tryptophan hydroxylase inhibitors, All stub articles, Nervous system ...
Other causes can include aromatic L-amino acid decarboxylase deficiency, postencephalitic Parkinson's, Tourette's syndrome, ... "Aromatic l-amino acid decarboxylase deficiency: An extrapyramidal movement disorder with oculogyric crises". European Journal ...
Facchini PJ, Huber-Allanach KL, Tari LW (May 2000). "Plant aromatic L-amino acid decarboxylases: evolution, biochemistry, ... Hydroxycinnamic acids are then transferred to serotonin from hydroxycinnamoyl-CoA esters by hydroxycinnamoyl-CoA: serotonin N-( ... Chemically, it is an amide formed between serotonin and ferulic acid. It has in vitro anti-atherogenic activity. Serotonin ... Kang S, Kang K, Lee K, Back K (December 2007). "Characterization of rice tryptophan decarboxylases and their direct involvement ...
Aromatic-L-amino-acid decarboxylase Ornithine decarboxylase Calculated using Advanced Chemistry Development (ACD/Labs) Software ... Pyridoxal phosphate is a cofactor of aromatic L-amino acids decarboxylase. This allows for conversion of 5-hydroxytryptophan (5 ... The α-amino group of the amino acid substrate displaces the ε-amino group of the active-site lysine residue in a process known ... Metabolism and biosynthesis of GABA (γ-aminobutyric acid). Pyridoxal phosphate is a cofactor of glutamic acid decarboxylase ( ...
... carbidopa and benserazide are aromatic L-amino acid decarboxylase (AADC) inhibitors. Without administration of tolcapone, the ... It melts at 143 to 146 °C (289 to 295 °F), is practically insoluble in water and acids but soluble in 0.1 M aqueous sodium ... hydroxylation by CYP3A4 and CYP2A6 with subsequent oxidation to a carboxylic acid, and possibly a minor path with reduction to ... in 0.1 M hydrochloric acid / ethanol). Its chemical name is 3,4-dihydroxy-4'-methyl-5-nitrobenzophenone. A synthesis of ...
The enzyme aromatic L-amino acid decarboxylase (AADC) yields tryptamine via decarboxylation of Trp. Tryptamine can be ... Oxidative deamination of Trp by aromatic amino acid aminotransferases (ArAT) or L-amino oxidases (LAAO), one of which is the ... accumulation of FICZ in skin γδ T cells is regulated by the activation marker CD69 in combination with the aromatic-amino-acid- ... It was originally identified as a photooxidized derivative of the amino acid tryptophan and suggested to be the endogenous ...
2017). "Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency". Orphanet ... Over time, the treatment with folinic acid has shown to reduce a variety of symptoms of CFD. The treatment of folinic acid can ... and must be treated with folinic acid. Folinic acid is a metabolically active form of folate that can be easily introduced into ... Starting the folinic acid treatment before the age of six is more advantageous for the child with CFD. If the treatment is ...
It is metabolized by aromatic L-amino acid decarboxylase (AAAD), also known as DOPA decarboxylase (DDC). Patients with NOH have ... Droxidopa can be coupled with a peripheral aromatic L-amino acid decarboxylase inhibitor (AAADI) or DOPA decarboxylase ... is a synthetic amino acid precursor which acts as a prodrug to the neurotransmitter norepinephrine (noradrenaline). Unlike ...
Then it is subsequently decarboxylated to give dopamine by DOPA decarboxylase (aromatic L-amino acid decarboxylase). Dopamine ... and a small number of neurons in the medulla oblongata in the brain through a metabolic pathway that converts the amino acids ... Together, these effects increase blood glucose and fatty acids, providing substrates for energy production within cells ... 4-Dihydroxymandelic acid and Metanephrine. Extracts of the adrenal gland were first obtained by Polish physiologist Napoleon ...
... and aromatic-L-amino-acid decarboxylases. Group I pyridoxal-dependent decarboxylases Group III pyridoxal-dependent ... Pyridoxal-5'-phosphate-dependent amino acid decarboxylases can be divided into four groups based on amino acid sequence. Group ... group II pyridoxal-dependent decarboxylases are family of enzymes including aromatic-L-amino-acid decarboxylase (L-dopa ... "Functionally important residues of aromatic L-amino acid decarboxylase probed by sequence alignment and site-directed ...
... is a group II pyridoxal-dependent decarboxylase, along with aromatic-L-amino-acid decarboxylase, and ... Aromatic L-amino acid decarboxylase Tyrosine decarboxylase Decarboxylation Histamine Antihistamine Pyridoxal 5'-phosphate Mast ... "Studies on bacterial amino-acid decarboxylases: 4. l(-)-histidine decarboxylase from Cl. welchii Type A". The Biochemical ... Histidine decarboxylase exists as a homodimer, with several amino acids from the respective opposing chain stabilizing the HDC ...
... s may be used in combination with peripherally selective aromatic L-amino acid decarboxylase inhibitors ( ... The amino acids L-tryptophan and L-5-hydroxytryptophan (5-HTP; oxitriptan) are precursors of serotonin and melatonin, while the ... "Carbidopa/Oxytriptan - Evecxia - AdisInsight". v t e (Amino acids, Dietary supplements, Prodrugs, Monoamine precursors, All ... amino acids L-phenylalanine, L-tyrosine, and L-DOPA (levodopa) are precursors of dopamine, epinephrine (adrenaline), and ...
On the other hand, the possibility of blocking peripheral decarboxylation by adding an aromatic amino acid decarboxylase (AADC ... This reaction happen in the process of decarboxylation by aromatic amino acid decarboxylase (AADC) also called dopa- ... Vanilpyruvate is reduced to the final conversion: venillactate which are the same, predominantly by aromatic α-keto acid ... Some studies have proposed that 3-OMD increases homocysteine levels, and this amino acid induces cardiovascular disease and ...
July 2021). "Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to ... observation of dopamine restoration on seven patients between 4 and 9 years old affected by aromatic L-amino acid decarboxylase ... Neovasculogen is a plasmid encoding the CMV promoter and the 165 amino acid form of VEGF. The FDA approved Phase I clinical ... Gene therapy encapsulates many forms of adding different nucleic acids to a cell. Gene augmentation adds a new protein coding ...
... entacapone is given as an adjunct to levodopa and an aromatic amino acid decarboxylase inhibitor, carbidopa. Entacapone ... When administered with a decarboxylase inhibitor, COMT acts as the major metabolizing enzyme for levodopa and metabolizes it to ...
No matter the source of L-tryptophan, the biosynthesis begins with its decarboxylation by an aromatic amino acid decarboxylase ... In plants, the parent amino acid L-tryptophan is produced endogenously where in animals L-tryptophan is an essential amino acid ... is biosynthesized by aromatic L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Studies have ... DMT is commonly handled and stored as a hemifumarate, as other DMT acid salts are extremely hygroscopic and will not readily ...
... inhibits aromatic-L-amino-acid decarboxylase (DOPA decarboxylase or DDC), an enzyme important in the biosynthesis of ... "The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small ... Aromatic L-amino acid decarboxylase inhibitors, Antiparkinsonian agents, Peripherally selective drugs). ... Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, ...
... and the biosynthetic enzyme aromatic amino acid decarboxylase (AADC). Grandy DK, Miller GM, Li JX (February 2016). ""TAARgeting ... decreases in the urine and plasma levels of the PE metabolite phenylacetic acid and the precursors phenylalanine and tyrosine ...
... and levodopa is then converted into dopamine by the aromatic amino acid decarboxylase. Serotonergic neurons-serotonin. ... Dopamine is synthesized from the amino acid tyrosine. Tyrosine is catalyzed into levodopa (or L-DOPA) by tyrosine hydroxlase, ... Glutamate is one of two primary excitatory amino acid neurotransmitters, along with aspartate. Glutamate receptors are one of ... Glutamate is synthesized from the amino acid glutamine by the enzyme glutamate synthase. Dopaminergic neurons-dopamine. ...
... tyrosine hydroxylase and amino acid aromatic decarboxylase are physically and functionally coupled with VMAT2. It was initially ... and the biosynthetic enzyme aromatic amino acid decarboxylase (AADC). Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill ... Studies indicate that the amino acid residue His419, located on the domain between TMDs X and XI of rat VMAT1, plays a role in ... Scientists have used these tools to analyze DNA and amino acid sequences, and discovered that transporters in bacteria and ...
The S-enantiomer of methyldopa is a competitive inhibitor of the enzyme aromatic L-amino acid decarboxylase (LAAD), which ... Aromatic L-amino acid decarboxylase inhibitors, Alpha-1 adrenergic receptor agonists, Alpha-2 adrenergic receptor agonists, ...
In mammals, phenethylamine is produced from the amino acid L-phenylalanine by the enzyme aromatic L-amino acid decarboxylase ... the gene for aromatic amino acid decarboxylase (AADC), the major enzyme involved in the synthesis of the trace amines, is ... phenethylamine is synthesized in catecholamine neurons from L-phenylalanine by aromatic amino acid decarboxylase at ... Acetoacetic acid (AAA) and ß-phenylethylamine (PEA) performed best in this experiment. On beef meat pieces, PEA reduced the ...
... and tryptophan by the action of aromatic amino acid decarboxylase enzymes. They are deactivated in the body by the enzymes ... All monoamines are derived from aromatic amino acids like phenylalanine, tyrosine, ... Monoamine neurotransmitters are neurotransmitters and neuromodulators that contain one amino group connected to an aromatic ...
... which encodes an enzyme called aromatic L-amino acid decarboxylase. Babies with severe aromatic L-amino acid decarboxylase ... and can be corrected by folinic acid. Aromatic L-amino acid decarboxylase deficiency is an autosomal recessive condition, ... The aromatic L-amino acid decarboxylase deficiency enzyme is involved in the synthesis of dopamine and serotonin, both of which ... Aromatic L-amino acid decarboxylase deficiency, also known as AADC deficiency, is a rare genetic disorder caused by mutations ...
Fermentation of aromatic amino acids (in this case tryptophan) leads to a large variety of products that remain with their ... November 2017). "A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites". Nature. 551 (7682 ... The first one consists of the degradation of the amino acid into indole-3-acetate. And in the second step, IAD catalyzes the ... Tryptophan (Trp), Tyrosine (Tyr) and Phenylalanine (Phe) are aromatic aminoacids that can be degraded by certain types of ...
... is a peripherally acting aromatic L-amino acid decarboxylase or DOPA decarboxylase inhibitor, which is unable to ... "Effects of benserazide on L-DOPA-derived extracellular dopamine levels and aromatic L-amino acid decarboxylase activity in the ... Aromatic L-amino acid decarboxylase inhibitors, Antiparkinsonian agents, Peripherally selective drugs). ...
Aromatic L-amino acid decarboxylase inhibitor, a class of anti-Parkinson drugs Aromatic amino acids Histidine decarboxylase PDB ... Aromatic L-amino acid decarboxylase (AADC or AAAD), also known as DOPA decarboxylase (DDC), tryptophan decarboxylase, and 5- ... Aromatic-L-Amino-Acid+Decarboxylases at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Portal: Biology ( ... Aromatic L-amino acid decarboxylase is active as a homodimer. Before addition of the pyridoxal phosphate cofactor, the ...
Aromatic l-amino acid decarboxylase (AADC) deficiency is an inherited disorder that affects the way signals are passed between ... medlineplus.gov/genetics/condition/aromatic-l-amino-acid-decarboxylase-deficiency/ Aromatic l-amino acid decarboxylase ... Aromatic l-amino acid decarboxylase (AADC) deficiency is an inherited disorder that affects the way signals are passed between ... Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes. Mol Genet Metab. 2007 Apr;90(4): ...
Aromatic L-Amino Acid Decarboxylase There are always a true variety of stray cats and small rodents in the zoo, and these pets ... Aromatic L-Amino Acid Decarboxylase (2002) The Bax subfamily of Bcl2-related proteins is vital for apoptotic sign transduction ... Aromatic L-Amino Acid Decarboxylase We utilized epithelial MDCK cells stably expressing a conditional dynamic edition of Raf ( ... Aromatic L-Amino Acid Decarboxylase Mean beliefs and regular deviations (SD) produced from 5 indie experiments are shown (*** ...
AAADTooltip Aromatic L-amino acid decarboxylase. *Substrates→Products: L-DOPA (levodopa)→Dopamine ... Resorcylic acid lactones (e.g., zearalanone, α-zearalenol, β-zearalenol, zearalenone, zeranol (α-zearalanol), taleranol ( ... Quinolines (e.g., 4-hydroxyquinoline, 4-hydroxyquinoline-3-carboxylic acid, 5,7-CIQA, 7-CIQ, 7-TFQ, 7-TFQA) ...
Heterogenic Distribution of Aromatic L-Amino Acid Decarboxylase Neurons in the Rat Spinal Cord. In: Frontiers in Integrative ... Heterogenic Distribution of Aromatic L-Amino Acid Decarboxylase Neurons in the Rat Spinal Cord. / Ren, Liqun; Chen, Meng; ... Aromatic L-amino acid decarboxylase (AADC) is an essential enzyme in the synthesis of serotonin, dopamine, and certain trace ... N2 - Aromatic L-amino acid decarboxylase (AADC) is an essential enzyme in the synthesis of serotonin, dopamine, and certain ...
Dopa decarboxylase (DDC), or aromatic amino acid decarboxylase (AADC), is a pyridoxal 5-phosphate enzyme responsible for the ... Dopa decarboxylase (DDC), or aromatic amino acid decarboxylase (AADC), is a pyridoxal 5-phosphate enzyme responsible for the ... A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular ...
... dopa decarboxylase (aromatic L-amino acid decarboxylase); Drd1, dopamine receptor D1; Drd2, dopamine receptor D2; Drd3, ... DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanilic acid. n=9-10 per group. *p,0.05, **p,0.005, ****p,0.00005. Ghrelin- ...
Aromatic l-amino acid decarboxylase deficiency: MedlinePlus Genetics (National Library of Medicine) ... Malonyl-CoA decarboxylase deficiency: MedlinePlus Genetics (National Library of Medicine) * MECP2-related severe neonatal ... Sialic acid storage disease: MedlinePlus Genetics (National Library of Medicine) * Succinic semialdehyde dehydrogenase ...
ALDOMET (methyldopa) is an aromatic-amino-acid decarboxylase inhibitor in animals and in man. Although the mechanism of action ... Alpha-Linolenic Acid Blond Psyllium Calcium Cocoa Cod Liver Oil Coenzyme Q-10 Fish Oil Garlic Inositol Nicotinate Iron Olive ... Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues ... Methyldopa may interfere with measurement of: urinary uric acid by the phosphotungstate method, serum creatinine by the ...
2001) Noninvasive assessment of aromatic l-amino acid decarboxylase activity in aging rhesus monkey brain in vivo. Synapse 39: ... Similar to 6-[18F]fluorodopa (FDOPA), FMT is a substrate for aromatic amino acid decarboxylase, an enzyme in the dopamine ... While findings using FDOPA, another tracer targeting aromatic amino acid decarboxylase, have been mixed (Martin et al., 1989; ... FMT is oxidized to 6-[18F] fluorohydroxyphenylacetic acid, and its signal is trapped in the presynaptic terminal, unlike FDOPA ...
... and aromatic L-amino acid decarboxylase deficiency. PTC Therapeutics works in collaboration with various biotechnology and ...
4. Aromatic-L-amino-acid decarboxylase. General function:. Involved in carboxy-lyase activity. Specific function:. Catalyzes ... Phenethylamine can be biosynthesized from the amino acid phenylalanine by enzymatic decarboxylation. It is also found in many ... Phenylethylamine (PEA) is an aromatic amine, which is a colorless liquid at room temperature. It is soluble in water, ethanol, ... Davis BA, Kennedy SH, DSouza J, Durden DA, Goldbloom DS, Boulton AA: Correlations of plasma and urinary phenylacetic acid and ...
Please wait while your request is being verified ...
Macleaya cordata extract or benzoic acid have anti-inflammatory, antioxidant, and antimicrobial activities that makes them ... 1000mg/kg benzoic acid (MB). Compared with the CON diet, dietary MB or AGP increased the final weight and average daily gain, ... 1,000 mg/kg benzoic acid (MB). Compared with the CON diet, dietary MB or AGP increased the final weight and average daily gain ... and total short-chain fatty acids in the ileum or cecum compared with the CON and AGP groups (P , 0.05). Streptococcus ...
These disorders include GTP cyclohydrolase I deficiency (dopa-responsive dystonia), aromatic L-amino acid decarboxylase ... an amino acid neurotransmitter. Amino acids are the chemical building blocks that form proteins in the body. Neurotransmitters ... which is reduced or converted to 4-hydroxybutyric acid, also known as GHB (gamma-hydroxybutyric acid). GHB is a natural ... which is converted to 4-hydroxybutyric acid (4-HBA) or "GHB" (gamma-hydroxybutyric acid). Thus, individuals with SSADH ...
Aromatic L-Amino Acid Decarboxylase Deficiency (AADC). For a complete list of articles on Aromatic L-Amino Acid Decarboxylase ... "Aromatic L-Amino Acid Decarboxylase Deficiency: Clinical Features, Diagnosis, and Treatment of a New Inborn Error of ... "Clinical and Therapeutic Observations in Aromatic L- Amino Acid Decarboxylase Deficiency".. Swoboda K.J., Hyland K., Godstein D ...
Aromatic l-amino acid decarboxylases (AAADs) are a phylogenetically diverse group of enzymes responsible for the ... Full Paper -, Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin ... decarboxylation of aromatic amino acid substrates into their corresponding aromatic arylalkylamines. AAADs have been ... cubensis and offers a new tool for metabolic engineering of aromatic-amino-acid-derived natural products.. ...
Pearson, T.S., et al. (2021) Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of ... aromatic L-amino acid decarboxylase (AADC) deficiency characterized by deficient synthesis of dopamine and serotonin. ... Tags: Alzheimers Disease, Amino Acid, B Cell, Brain, Cell, Central Nervous System, Children, DNA, Dopamine, Enzyme, Gene, Gene ...
Please wait while your request is being verified ...
Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain ...
1972) Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem 19:1549-1559. ... The relative activity of cerebral aromatic l-amino acid decarboxylase (AADC) representing endogenous dopamine synthesis rate ... NAA concentration was measured by HPLC (L-8500 amino acid analyzer system, Hitachi). The amino acids are phenylalanine, ... in Peptide and amino acid transport mechanisms in the cerebral nervous system, Exchange diffusion of large neutral amino acids ...
Aromatic L-Amino-Acid Decarboxylase Deficiency Screening by Analysis of 3-O-Methyldopa in Dried Blood Spots: Results of a ... Aromatic L-amino acid decarboxylase deficiency (AADCd) is a rare recessive metabolic disorder caused by pathogenic homozygous ... Aromatic L-amino acid decarboxylase deficiency (AADCd) is a rare recessive metabolic disorder caused by pathogenic homozygous ... Fatty acid amide hydrolase (FAAH) is an enzyme that degrades anandamide, an endocannabinoid that modulates mesolimbic dopamine ...
Contents Summary Function Nervous system Hemoglobin synthesis Tryptophan metabolism Hormone function Nucleic acid synthesis ... In the brain, the PLP-dependent enzyme aromatic L-amino acid decarboxylase catalyzes the synthesis of two major ... During protein digestion, amino acids, including methionine, are released. Methionine is an essential amino acid and precursor ... such as hemoglobin and amino acid biosynthesis, as well as fatty acid metabolism. Of note, PLP also functions as a coenzyme for ...
Tieman, D.; Taylor, M.; Schauer, N.; Fernie, A. R.; Hanson, A. D.; Klee, H. J.: Tomato aromatic amino acid decarboxylases ... Deficiency of a plastidial adenylate kinase in Arabidopsis results in elevated photosynthetic amino acid biosynthesis and ...
Phosphate And On The Activity Of The Decarboxylase Of Aromatic Amino Acids As Well As Of Other Pyridoxal Phosphate-dependent ... "Effect Of Neurotropic Agents On Total Pyridoxal, Phosphate And On The Activity Of The Decarboxylase Of Aromatic Amino Acids As ... Phosphate And On The Activity Of The Decarboxylase Of Aromatic Amino Acids As Well As Of Other Pyridoxal Phosphate-dependent ... of gross behaviour and the level of pyridoxal phosphate as well as the activity of decarboxylase of aromatic amino acids, of ...
DIETHYLAMIDE AND BROMOLYSERGIC ACID DIETHYLAMIDE AS WELL AS CENTRALLY EFFECTIVE DOSES OF THE AROMATIC AMINO ACID DECARBOXYLASE ...
There are currently no approved therapies that address the underlying cause of aromatic L-amino acid decarboxylase (AADC) ... in patients living with aromatic L-amino acid decarboxylase (AADC) deficiency.. The one-time gene therapy was found to give ... AADC deficiency is a rare genetic condition caused by a mutation in the dopa decarboxylase (DDC) gene, resulting in a lack of ...
  • Aromatic l-amino acid decarboxylase (AADC) deficiency is a disease that affects the production of signals that allow cells in the nervous system to communicate with each other. (nih.gov)
  • When Do Symptoms of Aromatic L-amino acid decarboxylase deficiency Begin? (nih.gov)
  • Aromatic L-amino acid decarboxylase deficiency is a genetic disease. (nih.gov)
  • Aromatic l-amino acid decarboxylase deficiency is associated with various symptoms as severe developmental delay, oculogyric crises and autonomic dysfunction. (wikipedia.org)
  • Aromatic l-amino acid decarboxylase (AADC) deficiency is an inherited disorder that affects the way signals are passed between certain cells in the nervous system. (medlineplus.gov)
  • Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. (medlineplus.gov)
  • Because dopamine is the precursor for norepinephrine and epinephrine, AADC deficiency (or dopa decarboxylase (DDC) deficiency) results in severe combined deficiency of all of these four neurotransmitters: serotonin, dopamine, norepinephrine, and epinephrine. (medscape.com)
  • Did you mean Deficiency of "aromatic-L-amino-acid" carboxylase ? (nih.gov)
  • This report presents the case of an adult male with aromatic L-amino acid decarboxylase deficiency who developed serious cardiac rhythm disturbances during treatment with intravenous dopamine and norepinephrine for severe hypotension. (nih.gov)
  • Patients with aromatic L-amino acid decarboxylase deficiency may be prone to cardiac arrhythmias at rest and also may be exceptionally sensitive to exogenous catecholamines. (nih.gov)
  • Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. (nih.gov)
  • Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. (nih.gov)
  • Aromatic l-amino acid decarboxylase (AADC) deficiency is a very rare genetic disorder characterized by decreased activity of aromatic l-amino acid decarboxylase, an enzyme involved in the building (synthesis) of neurotransmitters (dopamine and serotonin), which are responsible for the communication between neurons in the nervous system. (ericpedersen.org)
  • Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare inherited autosomal recessive disorder of biogenic amine metabolism. (intd-online.org)
  • Many of the common symptoms of CP are similar to other neurotransmitter disorders, such as Aromatic L-amino Acid Decarboxylase (AADC) deficiency, resulting in potential misdiagnosis. (pharmiweb.com)
  • Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare genetic disorder that leads to near absent levels of the brain chemicals serotonin and dopamine. (nih.gov)
  • 1. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma. (nih.gov)
  • Aromatic l-amino acid decarboxylase (AADC) deficiency is an extremely rare disorder that is difficult to diagnose. (ptcbio.com)
  • Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare, genetic disorder that affects the central nervous systems of young patients. (checkrare.com)
  • dopamine has also been linked to the inborn metabolic disorder aromatic l-amino acid decarboxylase deficiency. (foodb.ca)
  • Aromatic L-amino acid decarboxylase (AADC or AAAD), also known as DOPA decarboxylase (DDC), tryptophan decarboxylase, and 5-hydroxytryptophan decarboxylase, is a lyase enzyme (EC 4.1.1.28), located in region 7p12.2-p12.1. (wikipedia.org)
  • The enzyme aromatic L-amino acid decarboxylase (AADC) is involved in the biosynthesis of the monoamine neurotransmitters serotonin and dopamine. (medscape.com)
  • Aromatic L-amino acid decarboxylase (AADC) is required for the synthesis of the neurotransmitters dopamine and serotonin. (nih.gov)
  • An association with the T allele of rs11575542 coding for an arginine to glutamine substitution in the L-aromatic amino acid decarboxylase (AADC) enzyme was replicated in a meta-analysis of 3 independent cohorts. (painscience.com)
  • Biggest current partners include Charles Rivers Laboratories, Bayer, PTC Therapeutics (Aromatic l amino acid decarboxylase AADC). (moiglobal.com)
  • L-DOPA decarboxylase (DDC) is an enzyme that catalyses, mainly, the decarboxylation of L -DOPA to dopamine and was found to be involved in many malignancies. (nature.com)
  • L -DOPA decarboxylase (DDC) is a pyridoxal 5-phosphate (PLP)-dependent enzyme that catalyses the decarboxylation of 3,4-dihydroxy- L -phenylalanine ( L -DOPA) to dopamine (DA) and 5-hydroxy- L -tryptophan (S-HTP) to serotonin (5-HT) ( Christenson et al, 1972 ). (nature.com)
  • Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. (nih.gov)
  • Only methyldopa, the L-isomer of alpha-methyldopa, has the ability to inhibit dopa decarboxylase and to deplete animal tissues of norepinephrine. (nih.gov)
  • 15. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans. (nih.gov)
  • 20. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion. (nih.gov)
  • Our Anti-DOPA Decarboxylase rabbit polyclonal primary antibody from PhosphoSolutions is produced in-house. (aveslabs.com)
  • It detects bovine, human, mouse, and rat DOPA Decarboxylase and is antigen affinity purified from pooled serum. (aveslabs.com)
  • Bulk Order Inquiry for Anti-DOPA Decarboxylase Antibody ------- (please add any order requirements, including desired quantity, timing, etc. (aveslabs.com)
  • SDS denatured, recombinant bovine aromatic DOPA decarboxylase expressed in E. coli and purified from inclusion bodies. (aveslabs.com)
  • Affinity labelling of pig kidney Dopa decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. (univr.it)
  • For example, histamine is biosynthesised strictly via the enzyme histidine decarboxylase in humans and other organisms. (wikipedia.org)
  • in particular, PLP is the cofactor for the enzyme kynureninase, which catalyzes the conversion of 3-hydroxykynurenine to 3-hydroxyanthranilic acid. (oregonstate.edu)
  • Once L-Dopa crosses the blood-brain barrier, it is converted into dopamine by the enzyme aromatic L-amino acid decarboxylase (AAAD). (vitanetonline.com)
  • The lack of this enzyme prevents cholesterol from being converted into a bile acid called chenodeoxycholic acid. (rarediseases.org)
  • The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics. (omeka.net)
  • Addition of the aromatic amino acid decarboxylase inhibitor, NSD-1015 (10 microM), to Krebs'-Ringer phosphate (KRP) superfusion medium, significantly increased the release of dopamine in vitro from superfused corpus striatum tissue fragments of male rats. (omeka.net)
  • Although the putative role of NSD-1015 is as an aromatic amino acid decarboxylase inhibitor, the present results demonstrate that, either as a result of this function and/or in addition to this role, NSD-1015 is a potent activator of the release of dopamine. (omeka.net)
  • McDermott J, "The aromatic amino acid decarboxylase inhibitor, NSD-1015, increases release of dopamine: response characteristics. (omeka.net)
  • 13. Molecular detection of dopamine decarboxylase expression by means of reverse transcriptase and polymerase chain reaction in bone marrow and peripheral blood: utility as a tumor marker for neuroblastoma. (nih.gov)
  • serotonin from the amino acid tryptophan and dopamine from L-3,4-dihydroxyphenylalanine (L-Dopa). (oregonstate.edu)
  • Tyrosine hydroxylase converts tyrosine to 3,4-dihydroxyphenylalanine (DOPA), which is converted to dopamine under the effect of aromatic l-amino acid decarboxylase, then dopamine β-hydroxylase converts dopamine to norepinephrine and phenylethanolamine N -methyltransferase converts norepinephrine to epinephrine. (medscape.com)
  • 1997. Inhibition of L-aromatic amino acid decarboxylase by polychlorinated biphenyls. (cdc.gov)
  • The activity of tryptophan hydroxylase (EC 1.14.16.4) from rat brain was significantly decreased 1 h following a single systemic injection of 3,4-methylenedioxymethamphetamine (MDMA) when assessed ex vivo by radioenzymatic assay or in vivo by the quantitation of 5-hydroxytryptophan accumulation following central L-aromatic amino acid decarboxylase inhibition. (erowid.org)
  • The diagnosis of these disorders is almost exclusively based on clinical signs and symptoms leading to measurement of metabolites in CSF, specifically the quantitative determination of the neurotransmitters or their metabolites, that is the amino acids glutamate, glycine and GABA, the acidic metabolites of the biogenic monoamines, and tetrahydrobiopterin metabolites. (novapublishers.com)
  • Other neurotransmitters, including glycine, D-serine, glutamate, histamine, and γ-aminobutyric acid (GABA), are also synthesized in reactions catalyzed by PLP-dependent enzymes (7) . (oregonstate.edu)
  • Aminoaciduria is an abnormally high amount of amino acids in the urine. (nih.gov)
  • A reduction in PLP availability appears to primarily affect kynureninase activity, limiting NAD production and leading to higher concentrations of kynurenine, 3-hydroxykynurenine, and xanthurenic acid in blood and urine ( Figure 2 ) (9) . (oregonstate.edu)
  • Phenylketonuria (PKU) is a type of amino acid metabolism disorder. (nih.gov)
  • Compounds and drugs that block or inhibit the enzymatic action of AROMATIC AMINO ACID DECARBOXYLASES . (bvsalud.org)
  • One group of these disorders is amino acid metabolism disorders. (nih.gov)
  • Overview of Amino Acid Metabolism Disorders (Merck & Co., Inc. (nih.gov)
  • Overview of Amino Acid Metabolism Disorders - Learn about the causes, symptoms, diagnosis & treatment from the Merck Manuals - Medical Consumer Version. (nih.gov)
  • CDDs are slowly metabolized in mammalian tissues via oxidation and reductive dechlorination reactions catalyzed by cytochrome P450 enzymes, followed by conjugation to more polar molecules such as glutathione and glucuronic acid (ATSDR 1998). (cdc.gov)
  • 4. Combined measurements of plasma aromatic L-amino acid decarboxylase and DOPA as tumour markers in diagnosis and follow-up of neuroblastoma. (nih.gov)
  • Methyldopa is an aromatic-aminoacid decarboxylase inhibitor in animals and in man. (nih.gov)
  • The dietary requirement for niacin and the niacin coenzyme , nicotinamide adenine dinucleotide (NAD), can be also met, though to a fairly limited extent, by the catabolism of the essential amino acid tryptophan in the tryptophan-kynurenine pathway ( Figure 2 ). (oregonstate.edu)
  • Tryptophan (TRP) is an essential amino acid, and it has been suggested that TRP intake at breakfast combined with daytime bright light exposure can increase nocturnal melatonin secretion. (springer.com)
  • Tryptophan (TRP) is an essential amino acid in humans. (springer.com)
  • 1994). Because of the long-half life of most of the halogenated aromatic hydrocarbons, animals or humans will be exposed for relatively long periods of time following single exposures. (cdc.gov)
  • Humans cannot produce TRP sufficiently by themselves, so this amino acid must be absorbed in the small intestine from protein-rich foods (for example, milk, eggs, meat, and beans). (springer.com)
  • The many biochemical reactions catalyzed by PLP-dependent enzymes are involved in essential biological processes, such as hemoglobin and amino acid biosynthesis, as well as fatty acid metabolism . (oregonstate.edu)
  • 1989. Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. (cdc.gov)
  • 5. 3,4-dihydroxyphenylalanine (dopa) metabolism and retinoic acid induced differentiation in human neuroblastoma. (nih.gov)
  • 11. Adrenergic enzymes in cultured mouse neuroblastoma: absence of detectable aromatic-L-amino-acid decarboxylase. (nih.gov)
  • Dialysis studies also suggest that the potential isoform responsible for DOPA decarboxylation has a greater binding affinity for PLP than that of 5-HTP decarboxylase. (wikipedia.org)
  • PLP is also a coenzyme for reactions that generate glucose from amino acids, a process known as gluconeogenesis (6) . (oregonstate.edu)
  • PLP functions as a coenzyme of 5-aminolevulinic acid synthase, which is involved in the synthesis of heme , an iron -containing component of hemoglobin . (oregonstate.edu)
  • Other Ingredients: Hypromellose (cellulose capsule), Microcrystalline Cellulose and Stearic Acid (vegetable source). (vitanetonline.com)
  • making a protein called system B(0) neutral amino acid transporter 1 (B0AT1). (nih.gov)
  • This protein transports certain protein building blocks ( amino acids ), namely those with a neutral charge, into cells. (nih.gov)
  • Plasma amino acids is a screening test, usually done on infants that looks at the amounts of amino acids in the blood. (nih.gov)
  • 3. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma. (nih.gov)
  • 7. Determination of urinary vanillactic acid and plasma dihydroxyphenylalanine as markers of non-secreting neuroblastoma by high-performance liquid chromatography with electrochemical detection. (nih.gov)
  • Long-term therapy with chenodeoxycholic acid has been effective in treating affected individuals. (rarediseases.org)
  • this protein complex absorbs particular protein building blocks ( amino acids ) back into the blood. (nih.gov)